Nuvation Bio Inc.
NUVB
$4.38
-$0.12-2.67%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.41% | 5.45% | -10.84% | -7.67% | -19.98% |
| Total Depreciation and Amortization | 0.94% | 50.00% | 14.84% | 41.55% | 35.19% |
| Total Amortization of Deferred Charges | 3.15% | 1,661.11% | -- | -- | -- |
| Total Other Non-Cash Items | 14.56% | 4.37% | 36.09% | -22.03% | 93.75% |
| Change in Net Operating Assets | 27.52% | -4,562.37% | -92.97% | 140.90% | -235.68% |
| Cash from Operations | 43.78% | -9.78% | -13.02% | 7.94% | -48.95% |
| Capital Expenditure | -641.67% | 93.37% | -151.39% | -653.85% | 108.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 190.23% | -275.47% | 1.48% | 4.63% | 77.18% |
| Cash from Investing | 190.13% | -276.07% | 1.28% | 4.66% | 77.81% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | -16,994.12% | 59.04% | 68.91% | 93.00% | -137.94% |
| Issuance of Common Stock | 1,420.79% | -56.91% | 19.69% | -6.64% | -30.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 100.17% | -- | -- | -- |
| Cash from Financing | 1,509.38% | -99.74% | 35,196.17% | 160.89% | 41.48% |
| Foreign Exchange rate Adjustments | -250.00% | 50.00% | -184.77% | -86.48% | 250.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 143.73% | -174.54% | 1,532.06% | 115.47% | 233.84% |